ELOCTATE

This brand name is authorized in Brazil, Canada, Hong Kong SAR China, Japan, New Zealand.

Active ingredients

The drug ELOCTATE contains one active pharmaceutical ingredient (API):

1	Coagulation factor VIII UNII 839MOZ74GK - ANTIHEMOPHILIC FACTOR HUMAN
	Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X (factor Xa). Haemophilia A is a sex-linked hereditary disorder of blood coagulation due to decreased levels of factor VIII:C. By replacement therapy the plasma levels of factor VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies.
	Read more about Coagulation factor VIII

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ELOCTATE Powder for solution, lyophilized	MPI, CA: SPM	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD02	Coagulation factor VIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	538318010002207, 538318010002307, 538318010002407, 538318010002507, 538318010002607, 538318010002707, 538318010002807, 576720070079717, 576720070079817, 576720070079917, 576720070080017, 576720070080117, 576720070080217, 576720070080317
CA	Health Products and Food Branch	02430290, 02430304, 02430312, 02430320, 02430339, 02430347, 02430355
HK	Department of Health Drug Office	66994, 66995, 66996, 66997
JP	医薬品医療機器総合機構	6343442D1022, 6343442D2029, 6343442D3025, 6343442D4021, 6343442D5028, 6343442D6024, 6343442D7020, 6343442D8027
NZ	Medicines and Medical Devices Safety Authority	17412, 17413, 17414, 17415, 17416, 17417, 17422